Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Alexei Zelenev"'
Publikováno v:
The Lancet HIV. 7:e121-e128
Summary Background As HIV incidence and mortality continue to increase in eastern Europe and central Asia, particularly among people who inject drugs (PWID), it is crucial to effectively scale-up opioid agonist therapy (OAT), such as methadone or bup
Autor:
Eduardo Robles, Thomas W. Valente, Alexei Zelenev, Chinekwu Obidoa, Gayatri Moothi, Greg Palmer, Heather Mosher, Hee-Sung Shin, Margaret R. Weeks, Robert Heimer, Jianghong Li
Publikováno v:
AIDS and Behavior. 22:2340-2359
Intensive sociometric network data were collected from a typical respondent driven sample (RDS) of 528 people who inject drugs residing in Hartford, Connecticut in 2012-2013. This rich dataset enabled us to analyze a large number of unobserved networ
Publikováno v:
Clin Infect Dis
Background Hepatitis C virus (HCV) treatment as prevention (TasP) strategies can contribute to HCV microelimination, yet complimentary interventions such as opioid agonist therapies (OAT) with methadone or buprenorphine and syringe services programs
Autor:
Sergii Dvoriak, Sergii Filippovych, Ruthanne Marcus, Iuliia Makarenko, Alyona Mazhnaya, Alexei Zelenev, Frederick L. Altice, Martha J. Bojko, Iryna Pykalo
Publikováno v:
J Acquir Immune Defic Syndr
Background The HIV treatment cascade is a crucial tool to guide HIV prevention and treatment strategies. The extent to which opioid agonist treatments (OATs) such as methadone and buprenorphine influence this cascade was examined in a nationwide stud
Autor:
Alexei Zelenev
Publikováno v:
The lancet. HIV. 5(10)
BACKGROUND: Russia accounts for most new HIV infections among people who inject drugs (PWID) in Eastern Europe and Central Asia, and PWID have high overdose risk. Opioid agonist therapy (OAT) is prohibited, and coverage of needle/syringe programs (NS
Autor:
Olena Iakunchykova, Frederick L. Altice, Alexei Zelenev, Melissa Tracy, Anna Meteliuk, Alyona Mazhnaya
Background Among the estimated 340,000 people who inject drugs (PWID) in Ukraine, HCV prevalence is approximately 70%. As HCV treatment availability increases, an assessment of the HCV treatment cascade is needed to guide HCV prevention and treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8855270aae815eee00696f2713662b12
https://europepmc.org/articles/PMC5994183/
https://europepmc.org/articles/PMC5994183/
Autor:
Ruthanne Marcus, Lynn M. Madden, Alexei Zelenev, Julia Rozanova, Alyona Mazhnaya, Portia Shea, Frederick L. Altice
Publikováno v:
Drug and alcohol dependence. 190
Background Opioid agonist therapies (OAT) in Ukraine were first introduced in 2004 not as addiction treatment, but for HIV prevention. Numerous obstacles have thwarted OAT scale-up, including individual constraints and structural barriers. Methods A
Autor:
Robert Heimer, Adeeba Kamarulzaman, Forrest W. Crawford, Alexander R. Bazazi, Alexei Zelenev, Frederick L. Altice
Publikováno v:
AIDS and Behavior. 19:2347-2357
The HIV epidemic in Malaysia is concentrated among people who inject drugs (PWID). Accurate estimates of HIV prevalence are critical for developing appropriate treatment and prevention interventions for PWID in Malaysia. In 2010, 461 PWID were recrui
Autor:
Alexei Zelenev, Alison O. Jordan, Sandra A. Springer, Paul A. Teixeira, Angela Di Paola, Panagiotis Vagenas, Frederick L. Altice, Paula M. Frew, Anne C. Spaulding
Publikováno v:
AIDS Care. 28:22-31
The US HIV/AIDS epidemic is concentrated among men who have sex with men (MSM). Black men are disproportionately affected by incarceration and Black MSM experience higher infection rates and worse HIV-related health outcomes compared to non-Black MSM
Publikováno v:
Journal of Urban Health. 92:193-213
Buprenorphine maintenance therapy (BMT) expands treatment access for opioid dependence and can be integrated into primary health-care settings. Treating opioid dependence, however, should ideally improve other aspects of overall health, including pre